当前位置:首页 - 行情中心 - 易瑞生物(300942) - 财务分析 - 利润表

易瑞生物

(300942)

  

流通市值:22.52亿  总市值:22.52亿
流通股本:4.05亿   总股本:4.05亿

利润表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、营业总收入203,098,722.74128,365,795.0957,644,102.49263,229,020.8
  营业收入203,098,722.74128,365,795.0957,644,102.49263,229,020.8
二、营业总成本234,674,152.58154,899,413.6173,515,702.11260,412,512.64
  营业成本82,571,083.5352,663,264.2725,480,050.8394,808,397.72
  税金及附加511,078.23194,395.8349,654.191,845,239.94
  销售费用50,599,079.8333,591,775.515,914,105.7358,140,944.03
  管理费用35,511,502.4123,542,154.7210,857,448.2246,635,430.58
  研发费用35,703,412.4221,937,457.999,740,118.8241,446,356.76
  财务费用29,777,996.1622,970,365.311,474,324.3217,536,143.61
  其中:利息费用20,531,227.1713,509,322.76,716,880.7426,492,015.63
  其中:利息收入6,816,931.064,705,439.021,385,928.5210,213,743.02
三、其他经营收益
  加:公允价值变动收益132,409.63,132,844.981,249,384.052,949,322.7
  加:投资收益-2,284,484.37-1,494,35177,973.81-8,145,643.14
  资产处置收益-119,593.88-119,593.88-119,511.1612,214,552.49
  资产减值损失(新)-348,015.51-277,170.13--5,468,180.37
  信用减值损失(新)-3,594,750.57-2,420,052.83-667,516.32-4,875,158.47
  其他收益5,144,392.553,849,437.052,186,344.736,086,506.56
四、营业利润-32,645,472.02-23,862,504.33-13,144,924.515,577,907.93
  加:营业外收入708,090.05668,534.8155,571.657,825,634.49
  减:营业外支出2,013,455.93965,3171,258.5114,636.8
五、利润总额-33,950,837.9-24,159,286.52-13,090,611.3613,288,905.62
  减:所得税费用-7,165,512.52-4,762,515.69-2,604,885.66-2,177,451.14
六、净利润-26,785,325.38-19,396,770.83-10,485,725.715,466,356.76
(一)按经营持续性分类
  持续经营净利润-26,785,325.38-19,396,770.83-10,485,725.715,466,356.76
(二)按所有权归属分类
  归属于母公司股东的净利润-27,400,768.85-19,726,940.71-10,259,486.2213,743,333.96
  少数股东损益615,443.47330,169.88-226,239.481,723,022.8
  扣除非经常损益后的净利润-29,566,142.75-23,544,350.95-13,228,469.25-9,653,189.87
七、每股收益
  (一)基本每股收益-0.07-0.05-0.030.03
  (二)稀释每股收益-0.07-0.05-0.030.03
八、其他综合收益-1,005,395.29-444,264.96-217,813.54160,162.48
  归属于母公司股东的其他综合收益-1,005,395.29-444,264.96-217,813.54160,162.48
九、综合收益总额-27,790,720.67-19,841,035.79-10,703,539.2415,626,519.24
  归属于母公司股东的综合收益总额-28,406,164.14-20,171,205.67-10,477,299.7613,903,496.44
  归属于少数股东的综合收益总额615,443.47330,169.88-226,239.481,723,022.8
公告日期2026-10-282026-08-282026-04-272026-04-27
审计意见(境内)标准无保留意见
TOP↑